Urinary Tract Infection Testing Devices Market Poised to Hit $0.85 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Urinary Tract Infection Testing Devices Market Size Growth Forecast: What to Expect by 2025?
The market size for urinary tract infection testing devices has seen a robust expansion in the past few years. The value is projected to increase from $0.62 billion in 2024 to $0.66 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. Factors driving the growth during the historical period include a rise in the disease burden, an increase in the global instances of urinary tract infections, higher incidence of diabetes in lower-middle income countries, a surge in cases of hospital-obtained urinary tract infections, and a rise in the prevalence of antibiotic-resistant urinary tract infections.

How Will the Urinary Tract Infection Testing Devices Market Size Evolve and Grow by 2029?
The market for urinary tract infection testing devices is predicted to experience significant expansion in upcoming years, hitting $0.85 billion in 2029 with a 6.2% compound annual growth rate (CAGR). This projected growth in the forecast period is assumed to arise from the rise in self-testing and at-home kits, a growing inclination towards early diagnosis, and an increasing urgency to tackle antibiotic resistance. Some key trends anticipated within this period are the merging of AI and machine learning, the evolution of at-home testing, technological advancements, diagnostic tools based on nanotechnology, and those utilizing CRISPR.

View the full report here:
https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

What Drivers Are Propelling the Growth of Urinary Tract Infection Testing Devices Market Forward?
The rising frequency of urinary tract infections (UTIs) is anticipated to fuel the expansion of the urinary tract infection testing devices market in the future. UTIs are bacterial infections that can occur in any part of the urinary system such as kidneys, ureters, bladder or urethra, with Escherichia coli being the most prevalent trigger. Prolonged catheter use, poor hygiene habits, and growing antimicrobial resistance in hospitalized patients contribute to the increasing number of UTIs. Urinary tract infection testing devices aid in providing swift and precise diagnosis for patients suffering from UTIs. These tools allow healthcare practitioners to quickly detect the bacteria causing the infection and promptly initiate appropriate treatment, subsequently reducing complications, enhancing patient prognosis, and curbing the propagation of antimicrobial resistance in healthcare environments. For example, a report from the University of New South Wales, a prestigious public research university in Australia, stated in March 2024 that UTIs abundantly occur worldwide, with an estimated annual global occurrence of over 400 million instances. Thus, the accelerating occurrence of UTIs underpins the growth of the urinary tract infection testing devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20988&type=smp

What Are the Key Trends Driving Urinary Tract Infection Testing Devices Market Growth?
Leading corporations within the urinary tract infection testing devices market are prioritizing point-of-care (POC) testing instruments for swift, more accessible diagnostic services, enhancing patient results. The term Point-of-care (POC) refers to medical diagnostic tests carried out on or close to the location of patient care, such as clinics, immediate hospital settings, or even domestically, eliminating the necessity for lab sample dispatch. For example, Japan's Sysmex Corporation, a manufacturer of urinary tract infection testing devices, unveiled its PA-100 AST System in June 2023, a Point-of-Care Testing System specifically for determining antibiotic susceptibility. The system is capable of flagging bacteria presence in a short time, as well as evaluating the efficacy of antimicrobials. It can verify the existence of bacteria in urine specimens in about 10 minutes and offer susceptibility test outcomes in less than 30 minutes. Consequently, healthcare experts can carry out expedited testing straight from the urine specimens of individuals suspected of UTIs.

What Are the Key Segments in the Urinary Tract Infection Testing Devices Market?
The urinary tract infection testing devices market covered in this report is segmented -

1) By Product type: Instruments, Kits
2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing
3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:
1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)
2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20988&type=smp

Who Are the Key Players Shaping the Urinary Tract Infection Testing Devices Market's Competitive Landscape?
Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Stryker Corporation, Laboratory Corporation of America Holdings, Biomerieux Pvt. Ltd., Coloplast A/S, Sysmex Corporation, Quidel Corporation, Teleflex Incorporated, Teleflex Incorporated, Bio-Rad Laboratories, QIAGEN NV, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc.

What Geographic Markets Are Powering Growth in the Urinary Tract Infection Testing Devices Market?
North America was the largest region in the urinary tract infection testing devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20988

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.